Table 8 Relation between (FIB-4 score, fibroscan steatosis %, fibroscan fibrosis) and BMI:

From: Impact of thyroid dysfunction and diabetes on fibrosis and steatosis stages in metabolic dysfunction associated fatty liver disease

 

BMI

P value

BMI < 20

BMI 20–25

BMI 25–29

BMI > 30

N

%

N

%

N

%

N

%

FIB-4 score

Low

61

48.0

28

19.0

23

26.7

10

25.0

< 0.001

Intermediate

59

46.5

91

61.9

32

37.2

9

22.5

High risk

7

5.5

28

19.0

31

36.0

21

52.5

Fibroscan steatosis %

S0

0

0.0

0

0.0

0

0.0

0

0.0

0.365

S1

2

18.2

4

14.8

1

3.2

4

19.0

S2

8

72.7

16

59.3

22

71.0

15

71.4

S3

1

9.1

7

25.9

8

25.8

2

9.5

Fibroscan fibrosis

F1

7

43.8

11

37.9

8

23.5

4

17.4

0.138

F2

9

56.3

10

34.5

18

52.9

10

43.5

F3

0

0.0

8

27.6

8

23.5

8

34.8

F4

0

0.0

0

0.0

0

0.0

1

4.3

  1. BMI body mass index.